The EXPAREL is a bupivacaine liposome injectable suspension which is infiltrated via the TAP. The data will be presented at the annual American Society of Regional Anesthesia and Pain Medicine meeting in November.
Twenty-four patients were evaluated for the study after undergoing robotic prostatectomy with EXPAREL via TAP infiltration. On average, these patients required less than one oxycodone tablet per day from discharge to the 10-day visit. One hundred percent of subjects also reported being satisfied or extremely satisfied with the postsurgical pain control.
More Articles on Anesthesia:
5 Ways to Increase Anesthesia Cost-Effectiveness in ASCs
Dr. Gregory Opdahl Joins Tillamook County General Hospital
Terri Brandt-Corriea Named Director of Surgical, Anesthesia Services
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
